Clinical Observation of Immunotherapy Efficacy and Adverse Effects 
in Chinese Patients with Lung Squamous Cell Carcinoma

Clinical Observation of Immunotherapy Efficacy and Adverse Effects 
in Chinese Patients with Lung Squamous Cell Carcinoma

Background and objective Immune checkpoint inhibitors (ICIs) improved survival of partial patients with lung squamous cell carcinoma (LUSC). However, it was still insufficient of data in older patients. This study aimed to investigate the efficacy and toxicity of immunotherapy in patients with LUSC...

Full description

Bibliographic Details
Main Authors: Jiangyong YU, Xiaonan WU, Junling MA, Xi CHEN, Lin LI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-07-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
immunology therapy
efficacy
adverse effects
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.36

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.36

Similar Items